Presentation Information
[1P-156]Evaluation of utility of Alzheimer's disease model using patient iPSC-derived neurons
*Miyaka Ogihara1, Natsuko Hemmi1, Manabu Seo2, Motoki Azuma1 (1. RICOH Company, Ltd., Kanagawa, Japan, 2. Elixirgen Scientific, Inc., Baltimore, US)
Keywords:
Alzheimer's disease,iPSC-derived neuron,Drug discovery,Phenotypic screening
Password required to view
Abstract password authentication.
A password is required to view the full text of the abstract. Please enter the following password.
PW: Neuro2022
A password is required to view the full text of the abstract. Please enter the following password.
PW: Neuro2022